Clinical Trial Update: A Study of Dabrafenib Plus Cetuximab/Panitumumab With FOLFOX in the First Line of Therapy in People With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dabrafenib in combination with cetuximab or panitumumab plus FOLFOX as first-line therapy for metastatic colorectal cancer; currently R…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Dabrafenib (Dabrafenib)
• FOLFOX regimen (folinic acid (leucovorin) + fluorouracil + oxaliplatin)
• Panitumumab (panitumumab)

Snippet

Sponsor: Blokhin's Russian Cancer Research Center | Conditions: Neoplasms | Phase 2 | Status: RECRUITING